DK696988D0 - Nucleosider og nucleosidanaloge, farmaceutiske praeparater indeholdende disse forbindelser og fremgangsmaade til fremstilling af forbindelserne - Google Patents
Nucleosider og nucleosidanaloge, farmaceutiske praeparater indeholdende disse forbindelser og fremgangsmaade til fremstilling af forbindelserneInfo
- Publication number
- DK696988D0 DK696988D0 DK696988A DK696988A DK696988D0 DK 696988 D0 DK696988 D0 DK 696988D0 DK 696988 A DK696988 A DK 696988A DK 696988 A DK696988 A DK 696988A DK 696988 D0 DK696988 D0 DK 696988D0
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- formula
- nucleosidalalogs
- nucleosides
- procedures
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8701605A SE8701605D0 (sv) | 1987-04-16 | 1987-04-16 | Novel medicinal compounds |
SE8701605 | 1987-04-16 | ||
SE8800169 | 1988-04-06 | ||
PCT/SE1988/000169 WO1988008001A1 (en) | 1987-04-16 | 1988-04-06 | Nucleosides and nucleoside analogues, pharmaceutical composition and processes for the preparation of the compounds |
CA580141 | 1988-10-14 | ||
CA000580141A CA1336088C (en) | 1987-04-16 | 1988-10-14 | 1-(3'-substitued-2', 3'-dideoxy-d-ribofuranosyl) thymine and uracil |
Publications (3)
Publication Number | Publication Date |
---|---|
DK696988D0 true DK696988D0 (da) | 1988-12-15 |
DK696988A DK696988A (da) | 1989-01-31 |
DK168443B1 DK168443B1 (da) | 1994-03-28 |
Family
ID=25672174
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK696988A DK168443B1 (da) | 1987-04-16 | 1988-12-15 | Pyrimid-2-on-1-yl-forbindelser, farmaceutiske præparater indeholdende disse forbindelser og fremgangsmåde til fremstilling af forbindelserne |
DK911084A DK108491D0 (da) | 1987-04-16 | 1991-06-07 | Nucleosider og nucleosidanaloge samt farmaceutiske praeparater indeholdende disse forbindelser |
DK104994A DK104994A (da) | 1987-04-16 | 1994-09-13 | Anvendelse af beta-anomere forbindelser til fremstilling af farmaceutiske præparater til behandling eller forebyggelse af HIV eller hepatitis B Virus |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK911084A DK108491D0 (da) | 1987-04-16 | 1991-06-07 | Nucleosider og nucleosidanaloge samt farmaceutiske praeparater indeholdende disse forbindelser |
DK104994A DK104994A (da) | 1987-04-16 | 1994-09-13 | Anvendelse af beta-anomere forbindelser til fremstilling af farmaceutiske præparater til behandling eller forebyggelse af HIV eller hepatitis B Virus |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPH01503069A (da) |
AT (1) | ATE115958T1 (da) |
AU (1) | AU614082B2 (da) |
CA (1) | CA1336088C (da) |
DE (1) | DE3852531T2 (da) |
DK (3) | DK168443B1 (da) |
HU (1) | HU211547A9 (da) |
SE (1) | SE8701605D0 (da) |
WO (1) | WO1988008001A1 (da) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8629892D0 (en) * | 1986-12-15 | 1987-01-28 | Wellcome Found | Antiviral compounds |
US4950758A (en) * | 1988-01-20 | 1990-08-21 | Regents Of The University Of Minnesota | Optically-active isomers of dideoxycarbocyclic nucleosides |
US5631370A (en) * | 1988-01-20 | 1997-05-20 | Regents Of The University Of Minnesota | Optically-active isomers of dideoxycarbocyclic nucleosides |
US5175292A (en) * | 1988-01-20 | 1992-12-29 | Regents Of The University Of Minnesota | Intermediates for the preparation of dideoxycarbocyclic nucleosides |
WO1989008115A1 (fr) * | 1988-02-24 | 1989-09-08 | Institut De Recherches Chimiques Et Biologiques Ap | NOUVEAUX DERIVES DE LA DEOXY-2'-URIDINE SUBSTITUEE EN POSITION 5, 3' ou 5' PAR DES GROUPEMENTS alpha-AMINO ACYLES, PROCEDE POUR LEUR OBTENTION ET MEDICAMENTS LES CONTENANT |
US7119202B1 (en) | 1989-02-08 | 2006-10-10 | Glaxo Wellcome Inc. | Substituted-1,3-oxathiolanes and substituted-1,3-dioxolanes with antiviral properties |
US5198539A (en) * | 1988-08-19 | 1993-03-30 | Burroughs Wellcome Co. | 5'-esters of 2',3'-dideoxy-3'-fluoro-5-ethynyluridine |
US5157114A (en) * | 1988-08-19 | 1992-10-20 | Burroughs Wellcome Co. | 2',3'-dideoxy-3'-fluoro-5-ethyngluridine |
FI95384C (fi) * | 1989-04-06 | 1996-01-25 | Squibb Bristol Myers Co | Menetelmä 3'-deoksi-3'-substituoitujen metyylinukleosidien valmistamiseksi ja menetelmässä käytettäviä välituotteita |
FR2648045B1 (fr) * | 1989-06-13 | 1991-09-27 | Centre Nat Rech Scient | Composes oligonucleotidiques anomeres alpha inhibant la replication des retrovirus |
IE902574A1 (en) * | 1989-07-17 | 1991-02-27 | Univ Birmingham | Antiviral pyrimidine nucleosides |
AU6401490A (en) * | 1989-09-15 | 1991-04-18 | Southern Research Institute | 2'-deoxy-4'-thioribonucleosides as antiviral and anticancer agents |
US5591722A (en) * | 1989-09-15 | 1997-01-07 | Southern Research Institute | 2'-deoxy-4'-thioribonucleosides and their antiviral activity |
US5728575A (en) * | 1990-02-01 | 1998-03-17 | Emory University | Method of resolution of 1,3-oxathiolane nucleoside enantiomers |
GB9008696D0 (en) * | 1990-04-18 | 1990-06-13 | Wellcome Found | Anti-viral compounds |
US5521163A (en) * | 1990-07-13 | 1996-05-28 | University Of Birmingham | Antiviral pyrimidine nucleosides and methods for using same |
SE9003151D0 (sv) * | 1990-10-02 | 1990-10-02 | Medivir Ab | Nucleoside derivatives |
US6369066B1 (en) | 1990-11-13 | 2002-04-09 | Biochem Pharma, Inc. | Substituted 1,3-oxathiolanes with antiviral properties |
AU8864191A (en) * | 1990-11-13 | 1992-06-11 | Biochem Pharma Inc. | Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties |
US5587480A (en) * | 1990-11-13 | 1996-12-24 | Biochem Pharma, Inc. | Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties |
US6228860B1 (en) | 1990-11-13 | 2001-05-08 | Biochem Pharma Inc. | Substituted 1,3-oxathiolanes with antiviral properties |
JP3739785B2 (ja) * | 1991-11-26 | 2006-01-25 | アイシス ファーマシューティカルズ,インコーポレイティド | 修飾されたピリミジンを含有するオリゴマーを使用する増強された三重らせんおよび二重らせんの成形 |
TW393513B (en) * | 1991-11-26 | 2000-06-11 | Isis Pharmaceuticals Inc | Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines |
US6235887B1 (en) | 1991-11-26 | 2001-05-22 | Isis Pharmaceuticals, Inc. | Enhanced triple-helix and double-helix formation directed by oligonucleotides containing modified pyrimidines |
US20020120130A1 (en) | 1993-09-10 | 2002-08-29 | Gilles Gosselin | 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents |
US5587362A (en) * | 1994-01-28 | 1996-12-24 | Univ. Of Ga Research Foundation | L-nucleosides |
EP0763048A1 (en) * | 1994-05-31 | 1997-03-19 | Medivir Aktiebolag | Post exposure prevention of hiv |
US5612319A (en) * | 1994-05-31 | 1997-03-18 | Medivir Ab | Postexposure prevention of HIV infection or seroconversion |
US5703058A (en) | 1995-01-27 | 1997-12-30 | Emory University | Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent |
US6391859B1 (en) | 1995-01-27 | 2002-05-21 | Emory University | [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides |
US5808040A (en) * | 1995-01-30 | 1998-09-15 | Yale University | L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides |
EP0831852B1 (en) | 1995-06-07 | 2006-11-29 | Emory University | Nucleosides with anti-hepatitis b virus activity |
US5869493A (en) | 1996-02-16 | 1999-02-09 | Medivir Ab | Acyclic nucleoside derivatives |
US5753789A (en) * | 1996-07-26 | 1998-05-19 | Yale University | Oligonucleotides containing L-nucleosides |
MXPA00008348A (es) | 1998-02-25 | 2005-07-15 | Univ Emory | 2-fluronucleosidos. |
KR101195019B1 (ko) | 2000-10-18 | 2012-10-29 | 파마셋 인코포레이티드 | 바이러스 감염 및 비정상적인 세포 증식의 치료를 위한 변형된 뉴클레오시드 |
AP2009004812A0 (en) | 2006-10-10 | 2009-04-30 | Medivir Ab | HCV nucleoside inhibitor |
WO2014109384A1 (ja) * | 2013-01-10 | 2014-07-17 | 塩野義製薬株式会社 | 架橋型核酸誘導体の製造方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD75084A (da) * | ||||
US3116282A (en) * | 1960-04-27 | 1963-12-31 | Upjohn Co | Pyrimidine nucleosides and process |
FR2040177A1 (en) * | 1969-01-31 | 1971-01-22 | Robugen Gmbh | 2-deoxyribosyl-uracil derivs |
US3817982A (en) * | 1971-12-29 | 1974-06-18 | Syntex Inc | 2{40 ,3{40 -unsaturated nucleosides and method of making |
DE2918260A1 (de) * | 1979-05-07 | 1980-11-27 | Robugen Gmbh | Anwendung von 5-alkyl-2'-desoxyuridinen |
US4267171A (en) * | 1979-07-02 | 1981-05-12 | The Regents Of The University Of California | C-5 Substituted cytosine nucleosides |
US4247544A (en) * | 1979-07-02 | 1981-01-27 | The Regents Of The University Of California | C-5 Substituted uracil nucleosides |
DE2930904A1 (de) * | 1979-07-30 | 1981-02-19 | Kailash Kumar Dr Gauri | Verwendung von 5-alkyl-pyrimidinnucleosiden bei der bekaempfung von krebs |
DE3002197A1 (de) * | 1980-01-22 | 1981-07-23 | Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen | 5-alkylsubstituierte pyrimidin-nukleoside, verfahren zu deren herstellung und daraus hergestellte virostatische und cytostatische mittel |
DE3045375A1 (de) * | 1980-12-02 | 1982-07-01 | Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen | Neue substituierte pyrimidin-nukleoside mit antiviraler wirkung, verfahren zu deren herstellung und daraus zubereitete arzneiformen |
DE3229169A1 (de) * | 1982-08-05 | 1984-02-09 | Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen | Verwendung von 5-alkylpyrimidinnukleosiden und deren derivate als zytostatika |
US4724232A (en) * | 1985-03-16 | 1988-02-09 | Burroughs Wellcome Co. | Treatment of human viral infections |
CA1285935C (en) * | 1985-03-16 | 1991-07-09 | Janet Lister Rideout | Therapeutic nucleosides |
EP0196185B1 (en) * | 1985-03-16 | 1989-07-12 | The Wellcome Foundation Limited | Antiviral nucleosides |
AU591125B2 (en) * | 1985-05-15 | 1989-11-30 | Wellcome Foundation Limited, The | Therapeutic nucleosides |
DK167377B1 (da) * | 1985-09-17 | 1993-10-25 | Wellcome Found | 3'-azidopyrimidinnucleosider eller farmaceutisk acceptable salte eller estere deraf til anvendelse ved behandling af eller profylakse for en human retrovirusinfektion |
-
1987
- 1987-04-16 SE SE8701605A patent/SE8701605D0/xx unknown
-
1988
- 1988-04-06 WO PCT/SE1988/000169 patent/WO1988008001A1/en active IP Right Grant
- 1988-04-06 AT AT88903972T patent/ATE115958T1/de not_active IP Right Cessation
- 1988-04-06 AU AU16899/88A patent/AU614082B2/en not_active Ceased
- 1988-04-06 JP JP63503532A patent/JPH01503069A/ja active Pending
- 1988-04-06 DE DE3852531T patent/DE3852531T2/de not_active Expired - Fee Related
- 1988-10-14 CA CA000580141A patent/CA1336088C/en not_active Expired - Fee Related
- 1988-12-15 DK DK696988A patent/DK168443B1/da not_active IP Right Cessation
-
1991
- 1991-06-07 DK DK911084A patent/DK108491D0/da not_active Application Discontinuation
-
1994
- 1994-09-13 DK DK104994A patent/DK104994A/da not_active Application Discontinuation
-
1995
- 1995-05-12 HU HU95P/P00134P patent/HU211547A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
SE8701605D0 (sv) | 1987-04-16 |
WO1988008001A1 (en) | 1988-10-20 |
DK168443B1 (da) | 1994-03-28 |
DE3852531D1 (de) | 1995-02-02 |
DE3852531T2 (de) | 1995-08-10 |
DK108491A (da) | 1991-06-07 |
CA1336088C (en) | 1995-06-27 |
DK108491D0 (da) | 1991-06-07 |
DK104994A (da) | 1994-09-13 |
DK696988A (da) | 1989-01-31 |
AU1689988A (en) | 1988-11-04 |
JPH01503069A (ja) | 1989-10-19 |
HU211547A9 (en) | 1995-12-28 |
ATE115958T1 (de) | 1995-01-15 |
AU614082B2 (en) | 1991-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK696988D0 (da) | Nucleosider og nucleosidanaloge, farmaceutiske praeparater indeholdende disse forbindelser og fremgangsmaade til fremstilling af forbindelserne | |
DK0565549T3 (da) | Anvendelse af 1,3-oxathiolannucleosidanaloger til fremstilling af et præparat til behandling af hepatitis B | |
FI894545A (fi) | Terapeutiska nukleosider. | |
ES2149305T3 (es) | Compuestos de dibenzoxazepina sustituidos, composiciones farmaceuticas y procedimientos de uso. | |
DK0474712T3 (da) | Anvendelse af lysolecitinderivater til fremstilling af et farmaceutisk præparat | |
DE3262887D1 (en) | 1-beta-d-arabinofuranosyl-(e)-5-(2-halogenovinyl) uracil-5'-phosphate, preparation thereof and use thereof | |
DK0543000T3 (da) | Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-alkylpyridiner | |
DK0476066T3 (da) | Antiviralt præparat indeholdende 3-azido-2,3-dideoxy-5-methylcytidin | |
IL78954A0 (en) | Spiro-imidazolidines and pharmaceutical compositions containing them | |
DK0430551T3 (da) | Behandling af hjertedysfunktion med 15-keto-prostaglandinforbindelser | |
EP0446921A3 (en) | Optically active alkylene-dioxybenzene derivatives and their use in therapy | |
GB2122197B (en) | Antiviral guanine derivatives | |
IT1245631B (it) | Impiego di composti macrolidi come agenti anti-infiammatori per il trattamento di malattie provocate da cessione di istamina | |
ES8308335A1 (es) | Un procedimiento para la preparacion de nuevos derivados de desoxiuridina. | |
DE69011174D1 (de) | Catecholaminester. | |
GR1000522B (el) | Μεθοδος παρασκευης νεων αναλογων νουκλεοζιτων. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PBP | Patent lapsed |